Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Treasury Shares (2016 - 2026)

Standard Biotools has reported Treasury Shares over the past 4 years, most recently at $46.5 million for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $46.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.5 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $46.5 million for FY2025, 0.0% changed from the prior year.
  • Treasury Shares was $19.5 million for Q4 2025 at Standard Biotools, up from $18.6 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $19.5 million in Q4 2025 and troughed at -$18.6 million in Q3 2024.
  • The 5-year median for Treasury Shares is $1.0 million (2021), against an average of $2.2 million.
  • Year-over-year, Treasury Shares surged 961.63% in 2023 and then changed 0.0% in 2025.
  • A 4-year view of Treasury Shares shows it stood at $563000.0 in 2022, then surged by 961.63% to $6.0 million in 2023, then skyrocketed by 677.43% to $46.5 million in 2024, then changed by 0.0% to $46.5 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Treasury Shares are $46.5 million (Q4 2025), $46.5 million (Q3 2025), and $46.5 million (Q2 2025).